Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

AGM 2024 Presentation

November 22, 2024November 22, 2024 Alterity Therapeutics

AGM 2024 Presentation

Post navigation

Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium

Chairman’s Address 2024 Annual General Meeting

Related Posts

EMA publishes minutes recommending Orphan Drug Designation for PBT2

May 21, 2015August 16, 2022

Prana’s Alzheimer’s Disease Treatment Strategy Validated by Independent Study

March 6, 2014August 16, 2022

Alterity Therapeutics to Participate in the Benchmark Company Healthcare House Call Conference

May 26, 2022May 23, 2023

Leave a Reply Cancel reply

Your email address will not be published.Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Type in the text displayed above

Δ

Recent Posts

Chairman’s Address 2024 Annual General Meeting
AGM 2024 Presentation
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065